All NewsFDA BriefsOncology IconsSpecial ReportsThe Targeted PulseVoices from the Field
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
All VideosCase-Based Peer PerspectivesExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPivotal Practice Views with the Oncology BrothersPodcastsPrecision MedicineSpeaking Out
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
CASE-BASED ROUNDTABLEPARTNERS
CME/CEClinical TrialsPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
SUBSCRIBE
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
Spotlight -
  • Biomarker-Driven Lung Cancer
  • GIST
  • HER2 Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Small Cell Lung Cancer
  • Renal Cell Carcinoma
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
    • CASE-BASED ROUNDTABLE
    • PARTNERS
    • SUBSCRIBE
Advertisement

Chronic Myeloid Leukemia

home / expert-perspective-tumor-board / chronic-myeloid-leukemia

Chronic Myeloid Leukemia

Case 1: Refractory CP-CML With Multiple Comorbidities

EP. 1: Case 1: Refractory CP-CML With Multiple Comorbidities

May 28th 2019

Watch

Case 1: Molecular Testing & Treatment in CP-CML

EP. 2: Case 1: Molecular Testing & Treatment in CP-CML

May 28th 2019

Watch

Case 1: TKI Therapy in CP-CML

EP. 3: Case 1: TKI Therapy in CP-CML

May 28th 2019

Watch

Case 1: TKI Therapy and Sequencing Decisions in CP-CML

EP. 4: Case 1: TKI Therapy and Sequencing Decisions in CP-CML

May 28th 2019

Watch

Case 1: Ponatinib in Chronic-Phase CML

EP. 5: Case 1: Ponatinib in Chronic-Phase CML

May 28th 2019

Watch

Case 2: Relapsed CML With T315I Mutation

EP. 6: Case 2: Relapsed CML With T315I Mutation

May 28th 2019

Watch

Case 2: Ponatinib for T315I-Mutated CML

EP. 7: Case 2: Ponatinib for T315I-Mutated CML

May 28th 2019

Watch

Case 2: Additional Treatment Considerations for T315I-Mutated CML

EP. 8: Case 2: Additional Treatment Considerations for T315I-Mutated CML

May 28th 2019

Watch

Case 3: CML With Additional Cytogenetic Abnormalities

EP. 9: Case 3: CML With Additional Cytogenetic Abnormalities

May 28th 2019

Watch

Case 3: Selecting Between TKI Inhibitors

EP. 10: Case 3: Selecting Between TKI Inhibitors

May 28th 2019

Watch

Case 3: TKI Therapy and Treatment Monitoring in CML

EP. 11: Case 3: TKI Therapy and Treatment Monitoring in CML

May 28th 2019

Watch

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2024 MJH Life Sciences

All rights reserved.